CoChat

Revised Guidelines for Neonatal Screening Programmes for Primary Congenital Hypothyroidism

· 1999 · Hormone Research in Paediatrics
Cited by 98

The DOI matches its Crossref record.

Abstract

Since the first guidelines for neonatal screening for congenital hypothyroidism (CH) were issued by ESPE in 1993 [1], there have been considerable advances in our understanding of CH and our appreciation of the various geographical and logistic difficulties involved. Therefore, an updating of the guidelines is overdue. Experience from countries where screening began in the late 1970s and early 1980s has indicated that treatment should be started no later than the first 2 weeks of life using a ‘high’ dosage regime of L-thyroxine® (10–15 µg/kg/day). It has also been shown that the quality of long-term outcome is closely related to the quality of follow-up. In Eastern Europe, screening programmes for CH have either been started or will start soon in almost all countries, and although many programmes are operating satisfactorily, it is important to standardise screening procedures and management of suspected cases as much as possible in order to optimise outcome. A degree of uniformity throughout Europe would not only facilitate early detection and treatment of individual patients but give insight into the economic and epidemiological aspects of the screening programmes as well as the epidemiological aspect of CH.Adequate management of neonatal CH requires efficient capillary blood sampling, adequate testing, prompt communication of the screening results to a reference centre, accurate diagnosis and advice on treatment and follow-up by a paediatrician with endocrine expertise.The neonatal screening programme should be combined as much as possible with screening for other disorders, such as metabolic diseases and congenital adrenal hyperplasia, in order to minimise the discomfort of multiple blood samples for the babies, avoid multiple mailing and to reduce costs and risks of administrative errors.In Europe, two screening methods, depending on the aim of the screening, are used. If the aim of screening for CH lies in the prevention of severe mental retardation caused by primary CH, then thyroid-stimulating hormone (TSH) measurement alone will be used as the primary screening parameter. The TSH screening method is the most frequently used, because it is cheaper and easier to perform than the T4 method. Despite the elevated TSH levels seen just after birth in normal neonates, the TSH assay is sensitive enough to distinguish between normal newborns and neonates with primary CH to such an extent that the need for repeated measurements is low (recall rate 0.05% when TSH cut-off 15 mU/l of whole blood is used if measured with immunofluorometric methods, and 20 mU/l if measured radioimmunologically). However, the TSH method does not detect hypothalamo-pituitary forms of CH, and it has to be mentioned that some patients with central hypothyroidism will suffer from severe CH, but due to the low frequency of this disorder, it does not seem not to be justified to include T4 determinations into a TSH screening programme.The sensitivity of the TSH method for primary CH is 97.5%, the specificity is 99%. If the aim of the programme also comprises the detection of other forms of CH, the following method may be used: The T4 method is combined with either TSH determination or, in some centres, with both TSH and thyroid binding globulin (TBG) measurement. T4 is measured in all blood samples, TSH in the 20% lowest T4 samples (≤–0.8 SD) and TBG in the 5% lowest T4 values (≤–1.6 SD). This method of screening results in a sensitivity of 98% and a specificity of over 99% for all forms of CH [2]. The recall rate for this method is 0.4%, and the percentage of patients directly referred to a paediatrician 0.2%. Both methods are performed on dried capillary blood spots from heel puncture. Duplicate measurements are strongly advised.The screening results from both methods can be used to monitor iodine supply in the newborn population. This is an important issue in the many European countries which are still iodine deficient.It is usually recommended that capillary blood from a heel stab is performed before or at latest by day 5 (taking day of birth as day 1) in order to avoid unacceptable delay in diagnosis and treatment. If CH screening is combined with screening for congenital adrenal hyperplasia, capillary sampling should be performed not later than day 3. If, in the case of early discharge, sampling is performed 24 h after birth, this does not increase the recall rate provided that a sufficiently sensitive TSH method is used. The results of T4-TSH-TBG screening are not adversely affected either by early discharge. Indeed, cord blood sampling is possible for both methods, but this is too early for other neonatal screening programmes, i.e. phenylketonuria or congenital adrenal hyperplasia.Pre-term babies, especially those born before 32 weeks gestation, are particularly susceptible to transient hypothyroidism, nad also often show low TSH and T4 concentrations during the first weeks after birth, sometimes followed by TSH elevation. Therefo

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1159/000023433

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 98

Metadata

Venue
Hormone Research in Paediatrics
Publisher
S. Karger AG
Published
1999
Volume
52
Issue
1
Pages
49-52
ISSN
  • 1663-2818 (ISSN-L)
  • 1663-2826
OpenAlex
W2600307110
Cited by
98
References
0
FWCI
2.98
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Revised Guidelines for Neonatal Screening Programmes for Primary Congenital Hypothyroidism. https://app.cochat.ai/papers/10.1159/000023433
The paper
Revised Guidelines for Neonatal Screening Programmes for Primary Congenital Hypothyroidism. (1999). Hormone Research in Paediatrics. https://doi.org/10.1159/000023433

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.